Search

Search Constraints

You searched for: Author/Creator Hebraud, Benjamin

Search Results

2. Bortezomib, thalidomide, and dexamethasone with or without daratumumab for transplantation-eligible patients with newly diagnosed multiple myeloma (CASSIOPEIA): health-related quality of life outcomes of a randomised, open-label, phase 3 trial. Issue 12 (December 2020)

3. Clinical activity of a new regimen combining gemcitabine and alemtuzumab in high‐risk relapsed/refractory chronic lymphocytic leukemia patients. (17th September 2014)

4. Functional Comparison between Healthy and Multiple Myeloma Adipose Stromal Cells. (5th March 2020)

5. Health-related quality of life results from the IFM 2009 trial: treatment with lenalidomide, bortezomib, and dexamethasone in transplant-eligible patients with newly diagnosed multiple myeloma. Issue 6 (11th May 2020)

6. Heavy + light chain analysis to assign myeloma response is analogous to the IMWG response criteria. Issue 3 (4th March 2018)